MBX Biosciences, Inc. (NASDAQ:MBX – Get Free Report) shares rose 8.5% during mid-day trading on Wednesday after Mizuho raised their price target on the stock from $57.00 to $91.00. MBX Biosciences traded as high as $64.48 and last traded at $65.17. Wall Street Zen raised MBX Biosciences from a “sell” rating to a “hold” rating in a report on Tuesday. Eventide Asset Management LLC purchased a new stake in shares of MBX Biosciences in the 4th quarter worth about $28,071,000. Featured StoriesReceive News & Ratings for MBX Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MBX Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.